Introducing QIAsymphony Connect, our next-generation platform for automated clinical sample extraction. See what it can do for your lab.

TB Management

Transplant

Infectious Disease

Oncology

Sexual & Reproductive Health

Sample Processing

Solutions for Laboratory-Developed Tests

QIA Agent: A smarter way to search

Compare products and build your method with our AI tool. Find what you need in seconds – on one page.

Enzymes for molecular biology

Explore high-quality enzymes; now available as individual products.

Products and tools for your targets

Explore targets and pathways in their scientific context, find and customize products to study them, analyze data and plan follow-up studies – all in GeneGlobe.

Looking for a quick way to design experiments?
Looking for a quick way to design experiments?
Try the Workflow Configurator. A convenient tool to build experimental workflows and find products to match your needs.
Welcome to My QIAGEN
Dashboard
Account
Orders
Log Out
hero image
Virtual event

QIAsymphony Connect on tour: Voices from the lab

Upcoming
icon_0085_cc_gen_calendar-s
Sep 10, 2026
icon_0175_ls_qf_operating_hours-s
7:00 AM (GMT+0)
+1 other

Thinking of upgrading your sample extraction platform?
In just 20 minutes, see if QIAsymphony Connect is right for your lab.

You will learn

icon_0153_cc_gen_source_okay-s

How did early-access labs achieve faster, higher-throughput cfDNA workflows?

Hear from two high-throughput clinical testing labs that evaluated QIAsymphony Connect in cfDNA workflows, reporting 28% faster protocols, 39% higher sample throughput and 15% higher nucleic acid concentrations, alongside high-quality downstream sequencing results.
icon_0153_cc_gen_source_okay-s

How could QIAsymphony Connect improve your current testing?

See the system in action and assess how it could help reduce setup time, increase throughput, strengthen sample traceability and support same-day processing in your lab.
icon_0153_cc_gen_source_okay-s

How easy is it to upgrade or switch to QIAsymphony Connect?

Get practical guidance from QIAGEN experts on transitioning existing workflows to QIAsymphony Connect, including suitable QIAsymphony SP assays and key implementation considerations.

Agenda

  • See QIAsymphony Connect in action

    Watch a quick demo and see how the workflow is designed to make setup and sample processing faster and easier.

  • Upgrading to QIAsymphony Connect

    Join Adrian Syguda, PhD, Associate Director System Development at QIAGEN, for a chat about why you should make the switch to QIAsymphony Connect.

  • Early-access use in MRD testing at Myriad Genetics

    Hear from David Almanzar, PhD, Scientist at Myriad Genetics about his lab’s early-access experience, including how they achieved 28% faster processing, 39% higher sample throughput, consistent and reproducible cfDNA yields, and high-quality downstream WGS results.

  • Early-access use in high-throughput non-invasive prenatal testing at the Institute for Pathology and Genetics, Belgium

    Hear from Jean-Martin Billard, Ms, Biologist at IPG, about how he put the system to the test in NIPT and oncology workflows, demonstrating good performance across 500+ NIPT samples and 15% higher cfDNA concentrations in oncology samples, while improving workflow speed and efficiency.

  • Live Q&A throughout

Could QIAsymphony Connect fit into your lab’s automation strategy?

Image

Are you a clinical scientist, lab manager or molecular diagnostics lead? Join this short virtual event to take a closer look at the platform and evaluate it for your own lab. Whether you’re considering an upgrade from QIAsymphony SP or comparing automated extraction systems, this session will help support your next automation decision.

Speakers

David Almanzar, PhD, Scientist, Myriad Genetics, USA
David Almanzar earned his PhD in molecular biology from the University of Utah, where his research focused on meiotic DNA exchange in C. elegans. He joined Myriad Genetics in 2022 as a Scientist in early research and development, where he works on homologous recombination deficiency, liquid biopsy technologies and MRD assay development, with a focus on developing new approaches for genomic analysis.
David Almanzar, PhD, Scientist, Myriad Genetics, USA
Jean-Martin Billard, MS, Biologist, Institute of Pathology and Genetics (IPG), Belgium
Jean-Martin Billard studied biochemistry and molecular and cell biology at the University of Namur, Belgium where he earned his Master’s degree. Since 2017, he has worked at the Institute of Pathology and Genetics (IPG) in Belgium, first as a scientific expert in prenatal cytogenomics and currently as Manager of the Dispatching and Extraction team. He is also currently participating in implementing a pre-implantation genetic diagnostic testing service.
Jean-Martin Billard, MS, Biologist, Institute of Pathology and Genetics (IPG), Belgium
Adrian Syguda, PhD, Associate Director System Development, QIAGEN
Adrian Syguda holds a PhD in Biochemistry from Ruhr-University Bochum and serves as Associate Director, R&D at QIAGEN. He leads cross-functional development initiatives in laboratory automation and connectivity, combining scientific depth with strong execution to advance innovative, quality-driven solutions.
Adrian Syguda, PhD, Associate Director System Development, QIAGEN
Fernando Beils, Senior Vice President, Head of Global Commercial Operations, QIAGEN
Fernando Beils joined QIAGEN in 2023 as Senior Vice President, Head of the Molecular Diagnostics Business Area, and member of the Executive Committee, and was named Head of Global Commercial Operations in January 2025. He has worked in various global leadership roles within the diagnostics industry during his career, and most recently served as Vice President and General Manager of the Genetic Testing Solutions Business at Thermo Fisher Scientific. Prior to this role, he spent over two decades at Siemens in commercial, strategy and finance roles, and in his last role as Global Head of the Molecular Diagnostics Business Unit at Siemens Healthineers. He earned a degree in Business Administration from EWA Madrid and the University Mosbach School of Business.
Fernando Beils, Senior Vice President, Head of Global Commercial Operations, QIAGEN
Dr. Nathan Susnik, Senior Marketing Content Manager, QIAGEN
Nathan Susnik holds a PhD in molecular biology from Hannover Medical School. After his postdoctoral fellowship, he worked as a medical writer and associate scientific director. He is now a Senior Marketing Content Manger at QIAGEN, and in his free time, a published author of many short stories.
Dr. Nathan Susnik, Senior Marketing Content Manager, QIAGEN
Thumbnail Image
Thumbnail Image
Thumbnail Image
Thumbnail Image
Thumbnail Image

Fill out the form to take part in the event

Image

Looking ahead to Q-rious #15: Small size, big results

Join our next Q-rious episode where we introduce a tiny titan. QIAmini fits on a sheet of paper and expertly purifies nucleic acids while you keep your science moving. It's the device that proves in the world of molecular biology, little things can make colossal contributions.

Country and Language
Contact Us
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Sample to Insight
© QIAGEN 2013–26. All rights reserved
Trademarks & DisclaimersTerms & ConditionsPrivacyConsent ManagerAccessibilityCancellation and Returns